A detailed history of Gsa Capital Partners LLP transactions in Mereo Biopharma Group PLC stock. As of the latest transaction made, Gsa Capital Partners LLP holds 67,069 shares of MREO stock, worth $236,753. This represents 0.02% of its overall portfolio holdings.

Number of Shares
67,069
Holding current value
$236,753
% of portfolio
0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$3.45 - $4.87 $231,388 - $326,626
67,069 New
67,069 $276,000
Q1 2024

May 03, 2024

BUY
$2.3 - $4.05 $174,310 - $306,937
75,787 New
75,787 $250,000
Q4 2022

Feb 13, 2023

BUY
$0.5 - $1.01 $36,370 - $73,467
72,740 New
72,740 $55,000

Others Institutions Holding MREO

About Mereo Biopharma Group plc


  • Ticker MREO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,986,000
  • Market Cap $441M
  • Description
  • Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the tr...
More about MREO
Track This Portfolio

Track Gsa Capital Partners LLP Portfolio

Follow Gsa Capital Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.